KC

Khem Chand

Active Director Director DIN 08753363
DIN 08753363 First appointment Jun 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2020
Shareholding value •••• Premium profile

About Khem Chand

Data last updated:

Khem Chand is a Director at Kfs Biotech Private Limited (since 2020). The company operates in Pharma. Kfs Biotech Private Limited reported revenue of ₹8.15 Cr (FY 2025).

DIN 08753363
Primary Designation Director
Industry Pharma
First Appointment 04 Jun 2020
Oldest Company Age 6 yrs
Largest company Kfs Biotech Private Limited · ₹8.15 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kfs Biotech Private Limited U74900HP2020PTC007895
Director04 Jun 20202020₹8.15 Cr (FY 2025)Active

Board colleagues of Khem Chand

NameDINCompanyDesignation
Saleem Khan08753364Kfs Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Kfs Biotech Private Limited
Premium access

Shareholding and investment profile for Khem Chand

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Khem Chand

Khem Chand currently holds 1 directorship: Kfs Biotech Private Limited (Director, since 04 Jun 2020, revenue ₹8.15 Cr (FY 2025)).

Khem Chand was first appointed on 04 Jun 2020 as Director at Kfs Biotech Private Limited.

The current boards of Khem Chand's companies include Saleem Khan (Kfs Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available